Interestingly, the activity of central regulators of lipid homeostasis, SREBPs, has been implicated in the development of MASLD [29], as it can be triggered by excessive caloric intake, insulin resistance, or endoplasmic reticulum stress, contributes to the development of metabolic syndrome and MASLD [54]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.